DCLK1 and neuroblastoma: Moreover, a recent study demonstrated that doxycycline-inducible knockdown of DCLK1 inhibits proliferation, mitochondrial activity, and ATP synthesis in N1E-115 neuroblastoma cells and delays progression of N1E-115 tumor xenografts[13].